Europe Protein A Resin Market

Europe Protein A Resin Market Size, Share & Industry Trends Analysis Report By Product Type (Agarose-based, Glass/Silica-based and Organic Polymer-based), By End Use, By Type, By Application, By Country and Growth Forecast, 2022 - 2028

Report Id: KBV-13498 Publication Date: January-2023 Number of Pages: 96
Special Offering:
Industry Insights | Market Trends
Highest number of Tables | 24/7 Analyst Support

Market Report Description

The Europe Protein A Resin Market would witness market growth of 5.7% CAGR during the forecast period (2022-2028).

Protein A agarose bead is the frequently used matrix in industries or labs amidst different matrices. The agarose beads are interlinked to Protein A resin by amide bond creation. As a result, these beads have a high affinity & capacity for antibodies. Moreover, Protein A agar beads are also opposed to urea, chaotropic agents (like potassium thiocyanate & guanidine hydrochloride), and a wide pH range from 2-11.

Thus, it doesn’t get damaged or break easily even in severe elution conditions, like when detaching bound antibodies. Protein A resin has multiple applications, varying from its usage in biomanufacturing & bioprocessing assays to affinity chromatographic assays, and immunoprecipitation.

Because of its specificity, the resin is selected as a usual method to obtain antibodies in the purification procedure. Recombinant Streptococcal Protein A is the extensively used resin among all the accessible commercial proteins. It is delicate to alkaline situations and, therefore, cannot be utilized with cost-effective & rigorous NaOH and CIP-associated sanitization protocols.

The increasing population and the changes in demography will place constant stress on the UK’s system. It is estimated that approximately 26 million people have long-term health conditions. Government stats state that 63% of adults are overweight or obese. The number of people over 65 is estimated to rise from 18% in 2018 to 23.9% in 2036. With the increasing old aged population and development of well-organized and robust healthcare infrastructure, the market is predicted to grow in the Europe region.

The Germany market dominated the Europe Protein A Resin Market by Country 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $125.3 million by 2028.The UK market is anticipated to grow at a CAGR of 4.8% during (2022 - 2028). Additionally, The France market would exhibit a CAGR of 6.5% during (2022 - 2028).

Based on Product Type, the market is segmented into Agarose-based, Glass/Silica-based and Organic Polymer-based. Based on End Use, the market is segmented into Pharmaceutical & Biopharmaceutical Companies, Academic Research Institutes and Others. Based on Type, the market is segmented into Recombinant and Natural. Based on Application, the market is segmented into Antibody Purification and Immunoprecipitation. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.

Free Valuable Insights: The Global Protein A Resin Market will Hit $1.9 Billion by 2028, at a CAGR of 6.1%

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include General Electric (GE) Co. (GE Healthcare), Repligen Corporation, PerkinElmer, Inc, Thermo Fisher Scientific, Inc., Merck Millipore (Merck Group), Genscript Biotech Corporation, Agilent Technologies, Inc., Abcam plc, and Novasep Holdings SAS (Azulis Capital).

Scope of the Study

Market Segments Covered in the Report:

By Product Type

  • Agarose-based
  • Glass/Silica-based
  • Organic Polymer-based

By End Use

  • Pharmaceutical & Biopharmaceutical Companies
  • Academic Research Institutes
  • Others

By Type

  • Recombinant
  • Natural

By Application

  • Antibody Purification
  • Immunoprecipitation

By Country

  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe

Key Market Players

List of Companies Profiled in the Report:

  • General Electric (GE) Co. (GE Healthcare)
  • Repligen Corporation
  • PerkinElmer, Inc
  • Thermo Fisher Scientific, Inc.
  • Merck Millipore (Merck Group)
  • Genscript Biotech Corporation
  • Agilent Technologies, Inc.
  • Abcam plc
  • Novasep Holdings SAS (Azulis Capital)
Need a report that reflects how COVID-19 has impacted this market and its growth? Download Free Sample Now


Call: +1(646) 600-5072


  • Buy Sections of This Report
  • Buy Country Level Reports
  • Request for Historical Data
  • Discounts Available for Start-Ups & Universities

Unique Offerings Unique Offerings

  • Exhaustive coverage
  • The highest number of Market tables and figures
  • Subscription-based model available
  • Guaranteed best price
  • Support with 10% customization free after sale

Trusted by over
5000+ clients

Our team of dedicated experts can provide you with attractive expansion opportunities for your business.

Client Logo